PROCEPT BioRobotics Shareholders’ Equity Growth & History (PRCT)
PROCEPT BioRobotics's shareholders’ equity was $365.9M for fiscal 2025.
View full PROCEPT BioRobotics company overviewPROCEPT BioRobotics annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $365.9M | −$36.4M | −9.04% |
| 2024 | 2024-12-31 | $402.2M | $121.5M | +43.27% |
| 2023 | 2023-12-31 | $280.8M | $83.7M | +42.46% |
| 2022 | 2022-12-31 | $197.1M | −$70.0M | −26.22% |
| 2021 | 2021-12-31 | $267.1M | $450.0M | — |
| 2020 | 2020-12-31 | −$182.9M | — | — |
PROCEPT BioRobotics quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $340.1M | −$45.7M | −11.85% |
| Q1 2026 | 2026-03-31 | $347.7M | −$41.5M | −10.66% |
| Q4 2025 | 2025-12-31 | $365.9M | −$36.4M | −9.04% |
| Q3 2025 | 2025-09-30 | $380.3M | $139.1M | +57.65% |
| Q2 2025 | 2025-06-30 | $385.8M | $134.0M | +53.23% |
| Q1 2025 | 2025-03-31 | $389.2M | $125.1M | +47.38% |
| Q4 2024 | 2024-12-31 | $402.2M | $121.5M | +43.27% |
| Q3 2024 | 2024-09-30 | $241.2M | −$58.1M | −19.42% |
| Q2 2024 | 2024-06-30 | $251.8M | $95.9M | +61.50% |
| Q1 2024 | 2024-03-31 | $264.0M | $90.9M | +52.52% |
| Q4 2023 | 2023-12-31 | $280.8M | $83.7M | +42.46% |
| Q3 2023 | 2023-09-30 | $299.4M | $78.6M | +35.60% |
| Q2 2023 | 2023-06-30 | $155.9M | −$83.3M | −34.82% |
| Q1 2023 | 2023-03-31 | $173.1M | −$79.6M | −31.50% |
| Q4 2022 | 2022-12-31 | $197.1M | −$70.0M | −26.22% |
| Q3 2022 | 2022-09-30 | $220.8M | −$62.5M | −22.08% |
| Q2 2022 | 2022-06-30 | $239.2M | — | — |
| Q1 2022 | 2022-03-31 | $252.8M | — | — |
| Q4 2021 | 2021-12-31 | $267.1M | $450.0M | — |
| Q3 2021 | 2021-09-30 | $283.3M | — | — |
| Q4 2020 | 2020-12-31 | −$182.9M | — | — |
PROCEPT BioRobotics shareholders’ equity trends
Over the last five fiscal years, PROCEPT BioRobotics's shareholders’ equity increased from −$182.9M to $365.9M, a change of $548.8M. The latest reported quarter, Q2 2026, shows $340.1M.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PROCEPT BioRobotics source filings ↗